Zacks Investment Management Ligand Pharmaceuticals Inc Transaction History

Zacks Investment Management

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$69.53 - $79.33 $116,045 - $132,401	1,669 Added 17.06%	11,452 $825,000
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $13,210 - $15,072	-190 Reduced 1.91%	9,783 $705,000
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $654,926 - $768,718	9,973 New	9,973 $733,000
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $323,005 - $425,260	-4,010 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $4,657 - $6,589	52 Added 1.31%	4,010 $382,000
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $270,252 - $489,406	3,958 New	3,958 $443,000
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $761,424 - $1.02 Million	-7,188 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$128.36 - $272.13 $130,157 - $275,939	-1,014 Reduced 12.36%	7,188 $975,000
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $156,062 - $202,848	-739 Reduced 8.27%	8,202 $2.25 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $1.35 Million - $1.86 Million	8,941 New	8,941 $1.85 Million
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $1.15 Million - $1.51 Million	-8,282 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $61,356 - $70,285	-478 Reduced 5.46%	8,282 $1.13 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $1.06 Million - $1.21 Million	8,760	8,760 $1.19 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.